Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

This study aims to assess whether two blood markers - C-reactive protein (CRP) and D-dimer - can help predict cardiovascular complications in patients undergoing regular hemodialysis. Cardiovascular disease is a common and serious problem in dialysis patients, and early detection is important.

the study will include 100 adult patients from the Hemodialysis Unit at Assiut University Hospital. Participants will be divided into two groups: those with and those without known heart disease. Each participant will have a one-time blood test to measure CRP and D-dimer levels. In addition, an electrocardiogram (ECG) will be done once to check for signs of heart problems.

Eligibility criteria

Qualifiers

Adults aged ≥18 years

Disqualifiers

Acute or recent infection (within the past 4 weeks)

Trial design

Treatments tested in this trial

  • C-Reactive Protein (CRP) Test
  • D-dimer Test
  • Electrocardiogram (ECG)

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators